+4 more ↓
72%
Finnrick rating
#2 of 108 BPC-157 vendors
17 of 22 classifiable tests passed
natural 77% · customers 4.3★ (23)
methodology · Purity focus
Finnrick analysis · BPC-157

LiliPeptide BPC-157 is held back by a recent identity failure with 0 mg and 0% purity, interrupting an improving run after winter purity misses. The key detail is whether the listed March 11 batch anomaly is isolated despite nearby passes.

methodology →
vendor intelligence report
Vendor Intelligence Report: LiliPeptide

Public records and web artifacts leave the listed U.S. location unsupported and point toward a China/Hong Kong operating stack. The report maps the typo-domain network, PeptSlim/ElitePeptide66 overlap, rotating contact personas and post-payment courier-fee complaints.

27 pages5 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
94%
25
2
Tirzepatide
$0.53
80%
40
3
Retatrutide
$0.93
79%
141
4
BPC-157selected
$0.70
72%
22
5
PT-141
$0.75
65%
9
6
Ipamorelin
$0.95
62%
9
8
Tesamorelin
$2.50
52%
22
9
MOTS-c
$0.80
37%
9
10
CJC-1295
$2.20
25%
5
11
NAD+
$0.02
23%
4
12
TB-500
$1.75
22%
14
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%1 Jan 2026: 57%19 Jan 2026: 54%26 Jan 2026: 51%9 Feb 2026: 54%20 Feb 2026: 58%18 Mar 2026: 61%18 Mar 2026: 63%18 Mar 2026: 66%18 Mar 2026: 67%21 Mar 2026: 69%13 May 2026: 71%1 Jun 2026: 72%2 Jun 2026: 74%17 Jun 2026: 71%24 Jun 2026: 72%9 Aug 2026: current 72%57%63%72%Jan 26Aug 26
Showing BPC-157 tests only
LiliPeptide BPC-157 test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
24 Jun 2026Pass
Tested
lab nameView COA
17 Jun 2026Fail
Tested
lab nameView COA
2 Jun 2026Pass
Tested
lab nameView COA
1 Jun 2026Pass
Tested
lab nameView COA
13 May 2026Pass
Tested
lab nameView COA
21 Mar 2026Pass
Tested
lab nameView COA
18 Mar 2026Pass
Tested
lab nameView COA
18 Mar 2026Pass
Tested
lab nameView COA
18 Mar 2026Pass
Tested
lab nameView COA
18 Mar 2026Pass
Tested
lab nameView COA
1-10 of 22

About LiliPeptide test results from Finnrick

LiliPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 12 peptides and 304 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible LiliPeptide peptides in this dataset are BPC-157 (22 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.